Skip to main content

Advertisement

Log in

How good are the outcomes of instrumented debulking operations for symptomatic spinal metastases and how long do they stand? A subgroup analysis in the global spine tumor study group database

  • Original Article - Spine - Other
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Background

The benefits of surgery for symptomatic spinal metastases have been demonstrated, largely based on series of patients undergoing debulking and instrumentation operations. However, as cancer treatments improve and overall survival lengths increase, the incidence of recurrent spinal cord compression after debulking may increase. The aim of the current paper is to document the postoperative evolution of neurological function, pain, and quality of life following debulking and instrumentation in the Global Spine Tumor Study Group (GSTSG) database.

Methods

The GSTSG database is a prospective multicenter data repository of consecutive patients that underwent surgery for a symptomatic spinal metastasis. For the present analysis, patients were selected from the database that underwent decompressive debulking surgery with instrumentation. Preoperative tumor type, Tomita and Tokuhashi scores, EQ-5D, Frankel, Karnofsky, and postoperative complications, survival, EQ-5D, Frankel, Karnofsky, and pain numeric rating scores (NRS) at 3, 6, 12, and 24 months were analyzed.

Results

A total of 914 patients underwent decompressive debulking surgery with instrumentation and had documented follow-up until death or until 2 years post surgery. Median preoperative Karnofsky performance index was 70. A total of 656 patients (71.8%) had visceral metastases and 490 (53.6%) had extraspinal bone metastases. Tomita scores were evenly distributed above (49.1%) and below or equal to 5 (50.9%), and Tokuhashi scores almost evenly distributed below or equal to 8 (46.3%) and above 8 (53.7%). Overall, 12-month survival after surgery was 56.3%. The surgery resulted in EQ-5D health status improvement and NRS pain reduction that was maintained throughout follow-up. Frankel scores improved at first follow-up in 25.0% of patients, but by 12 months neurological deterioration was observed in 18.8%.

Conclusion

We found that palliative debulking and instrumentation surgeries were performed throughout all Tomita and Tokuhashi categories. These surgeries reduced pain scores and improved quality of life up to 2 years after surgery. After initial improvement, a proportion of patients experienced neurological deterioration by 1 year, but the majority of patients remained stable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Bakar D, Tanenbaum JE, Phan K, Alentado VJ, Steinmetz M, Benzel EC, Mroz TE (2016) Decompression surgery for spinal metastases: a systematic review. Neurosurg Focus 41:E2

    Article  Google Scholar 

  2. Boura T, Zairi F, Arikat A, Vieillard mH, Allaoui M, Assaker R (2018) Decision making for the surgical treatment of vertebral metastases among patients with short predicted survival. World Neurosurg 111: e573-e580

  3. Choi D, Crockard A, Bunger C et al (2010) Review of metastatic spine tumour classification and indications for surgery: the consensus statement of the global spine tumour study group. Eur Spine J 19:215–222

    Article  Google Scholar 

  4. Choi D, Fox Z, Albert T, Arts M, Balabaud L, Bunger C, Buchowski JM, Coppes MH, Depreitere B, Fehlings MG, Harrop J, Kawahara N, Martin-Benlloch JA, Massicotte EM, Mazel C, Oner FC, Peul W, Quraishi N, Tokuhashi Y, Tomita K, Verlaan JJ, Wang M, Crockard HA (2015) Prediction of Quality of Life and Survival After Surgery for Symptomatic Spinal Metastases: A Multicenter Cohort Study to Determine Suitability for Surgical Treatment. Neurosurgery 77:698–708 discussion 708

  5. Choi D, Ricciardi F, Arts M, Buchowski JM, Bunger C, Chung CK, Coppes M, Depreitere B, Fehlings M, Kawahara N, Leung Y, Martin-Benlloch A, Massicotte E, Mazel C, Meyer B, Oner C, Peul W, Quraishi N, Tokuhashi Y, Tomita K, Ulbricht C, Verlaan JJ, Wang M, Crockard A (2018) Prediction accuracy of common prognostic scoring systems for metastatic spine disease: results of a prospective international multicnetre study of 1469 patients. Spine 43:1678–1684

    Article  Google Scholar 

  6. Choi D, Pavlou M, Omar R, Arts M, Balabaud L, Buchowski JM, Bunger C, Chung CK, Coppes MH, Depreitere B, Fehlings MG, Kawahara N, Lee CS, Leung Y, Martin-Benlloch JA, Massicotte EM, Mazel C, Meyer B, Oner FC, Peul W, Quraishi N, Tokuhashi Y, Tomita K, Ulbricht C, Verlaan JJ, Wang M, Crockard HA (2019) A novel risk calculator to predict outcome after surgery for symptomatic spinal metastases; use of a large prospective patient database to personalise surgical management. Eur J Cancer 107:28–36

    Article  Google Scholar 

  7. Fehlings MG, Nater A, Tetreault L, Kopjar B, Arnold P, Dekutoski M, Finkelstein J, Fisher C, France J, Gokaslan Z, Massicotte E, Rhines L, Rose P, Sahgal A, Schuster J, Vaccaro A (2016) Survival and Clinical Outcomes in Surgically Treated Patients With Metastatic Epidural Spinal Cord Compression: Results of the Prospective Multicenter AOSpine Study. J Clin Oncol 34:268–276

  8. Gilbert RW, Kim JH, Posner JB (1978) Epidural spinal cord compression from metastastic tumor: diagnosis and treatment. Ann Neurol 3:40–51

    Article  CAS  Google Scholar 

  9. Ha KY, Kim YH, Ahn JH, Park HY (2015) Factors affecting survival in patients undergoing palliative spine surgery for metastatic lung and hepatocellular cancer: does the type of surgery influence the surgical results for metastatic spine disease? Clin Orthop Surg 7:344–350

    Article  Google Scholar 

  10. Ibrahim A, Crockard A, Antonietti P, Boriani S, Bünger C, Gasbarrini A, Grejs A, Harms J, Kawahara N, Mazel C, Melcher R, Tomita K (2008) Does spinal surgery improve the quality of life for those with extradural (spinal) osseous metastases? An international multicenter prospective observational study of 223 patients. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2007. J Neurosurg Spine 8:271–278

  11. Jansson KA, Bauer HCF (2006) Survival, complications and outcome in 282 patients operated for neurological deficit due to thoracic or lumbar spinal metastases. Eur Spine J 15:196–202

    Article  Google Scholar 

  12. Laufer I, Iorgulescu JB, Chapman T, Lis E, Shi W, Zhang Z, Cox BW, Yamada Y, Bilsky MH (2013) Local disease control for spinal metastases following "separation surgery" and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients. J Neurosurg Spine 18:207–214

    Article  Google Scholar 

  13. Matsumoto M, Tsuji T, Iwanami A, Watanabe K, Hosogane N, Ishii K, Nakamura M, Morioka H, Toyama Y (2013) Total en bloc spondylectomy for spinal metastasis of differentiated thyroid cancers: a long-term follow-up. J Spinal Disord Tech 26:E137–E142

    Article  Google Scholar 

  14. North RB, LaRocca VR, Schwartz J, North CA, Zahurak M, Davis RF, McAfee PC (2005) Surgical management of spinal metastases: analysis of prognostic factors during a 10-year experience. J Neurosurg Spine 2:564–573

    Article  Google Scholar 

  15. Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366:643–648

    Article  Google Scholar 

  16. Sakauro H, Hosono N, Mukai Y, Ishii T, Yonenobu K, Yoshikawa H (2004) Outcome of total en bloc spondylectomy for solitary metastasis of the thoracolumbar spine. J Spinal Disord Tech 17:297–300

    Article  Google Scholar 

  17. Spratt DE, Beeler WH, de Moraes FY, Rhines LD, Gemmete JJ, Chaudhary N, Shultz DB, Smith SR, Berlin A, Dahele M, Slotman BJ, Younge KC, Bilsky M, Park P, Szerlip NJ (2017) An integrated multidisciplinary algorithm for the management of spinal metastases: an international spine oncology consortium report. Lancet Oncol 18:e720–e730

    Article  Google Scholar 

  18. Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J (2005) A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 30:2186–2191

    Article  Google Scholar 

  19. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T (2001) Surgical strategy for spinal metastases. Spine 26:298–306

    Article  CAS  Google Scholar 

  20. Verlaan JJ, Choi D, Versteeg A, Albert T, Arts M, Balabaud L, Bunger C, Buchowski JM, Chung CK, Coppes MH, Crockard HA, Depreitere B, Fehlings MG, Harrop J, Kawahara N, Kim ES, Lee CS, Leung Y, Liu Z, Martin-Benlloch A, Massicotte EM, Mazel C, Meyer B, Peul W, Quraishi NA, Tokuhashi Y, Tomita K, Ulbricht C, Wang M, Oner FC (2016) characteristics of patients who survived < 3 months or > 2 years after surgery for spinal metastases: can we avoid inappropriate patient selection? J Clin Oncol 34:3054–3061

  21. Weigel B, Maghsudi M, Neumann C, Kretschmer R, Müller FJ, Nerlich M (1999) Surgical management of symptomatic spinal metastases. Postoperative outcome and quality of life Spine 24:2240–2246

    CAS  PubMed  Google Scholar 

  22. Yokogawa N, Murakami H, Demura S, Kato S, Yoshioka K, Hayashi H, Ishii T, Igarashi T, Fang X, Tsuchiya H (2014) Perioperative complications of total en bloc spondylectomy: adverse effects of preoperative irradiation. PLoS One 9:e98797

    Article  Google Scholar 

  23. Young RF, Post EM, King GA (1980) Randomized prospective comparison of laminectomy and radiotherapy. J Neurosurg 53:741–748

    Article  CAS  Google Scholar 

  24. Zairi F, Vieillard MH, Devos P, Rabih A, Gras L, Assaker R (2015) Management of neoplastic spinal tumors in a spine surgery care unit. Clin Neurol Neurosurg 128:35–40

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bart Depreitere.

Ethics declarations

Funding information

This work was funded by the Global Spine Tumor Study Group, a registered charity of England and Wales, Charity Commission number 1134934, and DePuy Synthes (Johnson and Johnson). This study was performed in part at University College London Biomedical Research Centre, which receives funding from the National Institute for Health Research, UK. The sponsors had no role in the design or conduct of this research.

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements) or nonfinancial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the local institutional research committees according to national regulations and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Statement of informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Spine - Other

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Depreitere, B., Ricciardi, F., Arts, M. et al. How good are the outcomes of instrumented debulking operations for symptomatic spinal metastases and how long do they stand? A subgroup analysis in the global spine tumor study group database. Acta Neurochir 162, 943–950 (2020). https://doi.org/10.1007/s00701-019-04197-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-019-04197-5

Keywords

Navigation